To investigate whether the level or subcellular localization of maspin helps predict the survival of ESCC patients, ESCC tissues were collected from 84 stage I-III patients who were eligible for and underwent surgical resection between 2003 and 2007. This evidence concerns the gene SERPINB5 and esophageal squamous cell carcinoma.